Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study

ACTA PHARMACOLOGICA SINICA · Published 2026-08-04 · DOI 10.1038/s41401-026-01881-y

Free full text

Authors (11)

Ana Peleteiro-Vigil, Sara Ortiz-Rivero, Yanira Izquierdo-Mateo, Laura Sanchez-Vicente, Ester González-Sánchez, Javier Vaquero, Juan Carlos Arevalo, Oscar Briz, Maria J. Monte, Jose J. G. Marin, Elisa Herraez

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Peleteiro-Vigil, A., Ortiz-Rivero, S., Izquierdo-Mateo, Y., et al. (2026). Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study. ACTA PHARMACOLOGICA SINICA. https://doi.org/10.1038/s41401-026-01881-y

Related articles